Announce Date | 05/16/2024 |
EPS Normalized Actual | $2.09 (Beat by $0.1) |
EPS GAAP Actual | $2.09 (Beat by $0.1) |
Revenue Actual | $6.245B |
Revenue Surprise | Beat by $6245M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Oct 2027 | 11.95 | 17.28 | 11.26144 | 12.72679 | 3 |
Oct 2026 | 10.28352 | 20.08 | 9.4 | 11.56 | 7 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2022 (May 2022) | 1.75 | 1.75 | 6.245B | 10.62% | 6245M |
FQ1 2022 (Jan 2022) | 2.02 | 2.02 | 6.271B | 17.68% | 6271M |
FQ4 2021 (Oct 2021) | 1.91 | 1.91 | 6.123B | 23.44% | 6123M |
FQ3 2021 (Aug 2021) | 1.89 | 1.89 | 6.196B | 29.07% | 6196M |
FQ2 2021 (May 2021) | 1.45 | 1.45 | 5.582B | 29.11% | 5582M |
FQ1 2021 (Jan 2021) | 1.23 | 1.23 | 5.162B | 19.37% | 5162M |
FQ4 2020 (Oct 2020) | 1.24 | 1.24 | 4.688B | 19.92% | 4688M |
FQ3 2020 (Jul 2020) | 0.92 | 0.92 | 4.395B | 18.95% | 4395M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Jan 2027) | 2.88 | -- | 2.79271 | 3.04441 | 11 |
FQ4 2026 (Oct 2026) | 2.36522 | -- | 2.29353 | 2.50024 | 6 |
FQ3 2026 (Jul 2026) | 2.3353 | -- | 2.26452 | 2.46861 | 6 |
FQ2 2026 (Apr 2026) | 2.25866 | -- | 2.1902 | 2.3876 | 6 |
FQ1 2026 (Jan 2026) | 2.31916 | -- | 2.24887 | 2.45155 | 6 |
FQ4 2025 (Oct 2025) | 2.35646 | -- | 2.28504 | 2.49098 | 7 |
FQ3 2025 (Jul 2025) | 2.26113 | -- | 2.1926 | 2.39021 | 7 |
FQ2 2025 (Apr 2025) | 2.17697 | -- | 2.11099 | 2.30124 | 7 |
FQ1 2025 (Jan 2025) | 2.13931 | -- | 2.07447 | 2.26143 | 7 |
FQ4 2024 (Oct 2024) | 2.07606 | -- | 2.01314 | 2.19457 | 11 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Jan 2027) | 8.08B | -- | 7.89B | 8.43B | 12 |
FQ4 2026 (Oct 2026) | 7.52B | -- | 7.35B | 7.85B | 7 |
FQ3 2026 (Jul 2026) | 7.48B | -- | 7.3B | 7.8B | 7 |
FQ2 2026 (Apr 2026) | 7.3B | -- | 7.13B | 7.62B | 7 |
FQ1 2026 (Jan 2026) | 7.41B | -- | 7.24B | 7.74B | 7 |
FQ4 2025 (Oct 2025) | 7.46B | -- | 7.29B | 7.79B | 6 |
FQ3 2025 (Jul 2025) | 7.31B | -- | 7.14B | 7.63B | 6 |
FQ2 2025 (Apr 2025) | 7.15B | -- | 6.99B | 7.47B | 6 |
FQ1 2025 (Jan 2025) | 7.05B | -- | 6.89B | 7.36B | 6 |
FQ4 2024 (Oct 2024) | 6.9B | -- | 6.74B | 7.2B | 12 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2022 (May 2022) | 1.75 | 1.75 | 100% | |
FQ1 2022 (Jan 2022) | 2.02 | 2.02 | 100% | |
FQ4 2021 (Oct 2021) | 1.91 | 1.91 | 100% | |
FQ3 2021 (Aug 2021) | 1.89 | 1.89 | 100% | |
FQ2 2021 (May 2021) | 1.45 | 1.45 | 100% | |
FQ1 2021 (Jan 2021) | 1.23 | 1.23 | 100% | |
FQ4 2020 (Oct 2020) | 1.24 | 1.24 | 100% | |
FQ3 2020 (Jul 2020) | 0.92 | 0.92 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2022 (May 2022) | $0B | $6.25B | $6245M | 100% |
FQ1 2022 (Jan 2022) | $0B | $6.27B | $6271M | 100% |
FQ4 2021 (Oct 2021) | $0B | $6.12B | $6123M | 100% |
FQ3 2021 (Aug 2021) | $0B | $6.2B | $6196M | 100% |
FQ2 2021 (May 2021) | $0B | $5.58B | $5582M | 100% |
FQ1 2021 (Jan 2021) | $0B | $5.16B | $5162M | 100% |
FQ4 2020 (Oct 2020) | $0B | $4.69B | $4688M | 100% |
FQ3 2020 (Jul 2020) | $0B | $4.4B | $4395M | 100% |